SAMANTHA CAPECE: Open Payments
NPI 1669057311 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 73 payments from 14 companies in 2025. Trend: 2023 $376 · 2024 $396 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 20 | $372 |
| ABBVIE INC. | 23 | $288 |
| Madrigal Pharmaceuticals | 6 | $206 |
| QOL Medical, LLC | 4 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $117 |
| Phathom Pharmaceuticals, Inc. | 5 | $107 |
| Braintree Laboratories, Inc. | 2 | $66 |
| Intercept Pharmaceuticals, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Janssen Biotech, Inc. | 1 | $30 |
Products named: IBSRELA, REZDIFFRA, RINVOQ, Sucraid, XIFAXAN, SKYRIZI, VOQUEZNA, SUFLAVE.
Industry payments across RI — which companies pay providers there.
